![]() |
产地 | 中国 |
品牌 | AntibodySystem |
保存条件 | -20 |
货号 | DHD30408 |
用途 | 科学研究 |
应用范围 | 仅用于科研 |
抗原来源 | 重组表达 |
保质期 | 一年 |
抗体名 | bavunalimab |
是否单克隆 | 是 |
克隆性 | 是 |
靶点 | CD223、CD152 |
适应物种 | human |
形态 | 液体 |
宿主 | human |
标记物 | 未标记 |
包装规格 | 100ug/支 |
亚型 | half-IGG1-kappa/(scFv-heavy-kappa)-h-CH2-CH3 |
标识物 | 保密 |
浓度 | 1mg/ml% |
免疫原 | 保密 |
是否进口 |
DHD30408
Humanized
Human
Liquid
0.01M PBS, pH 7.4.
1 mg/ml
>95%
Monoclonal
half-IGG1-kappa/(scFv-heavy-kappa)-h-CH2-CH3
Research Grade Pavunalimab Biosimilar
Bispecific,FDC,LAG3,Lymphocyte activation gene 3 protein,CD223,sLAG-3,LAG-3,CD152,Cytotoxic T-lymphocyte protein 4,CTLA-4,CTLA4,Cytotoxic T-lymphocyte-associated antigen 4
Protein A or G purified from cell culture supernatant.
Please contact with the lab for this information.
Mammalian cells
P18627 & P16410
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Bispecific, XmAb-22841, Bavunalimab, CAS: 2329669-78-3
For research use only. Not suitable for clinical or therapeutic use.